Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: YAZ — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for YAZ, a combined oral contraceptive containing drospirenone and ethinyl estradiol, by Bayer HealthCare Pharmaceut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • YAZ (DROSPIRENONE AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for YAZ (DROSPIRENONE AND ETHINYL ESTRADIOL)